F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer

This publication has 27 references indexed in Scilit:

• Role of fusion in radiotherapy treatment planning
  Seminars in Nuclear Medicine, 2003
• Diagnostic and Prognostic Value of [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography for Recurrent Head and Neck Squamous Cell Carcinoma
  Journal of Clinical Oncology, 2002
• Can positron emission tomography improve the quality of care for head-and-neck cancer patients?
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Diagnosis and Staging of Head and Neck Cancer
  JAMA Otolaryngology–Head & Neck Surgery, 2000
• Surveillance for Recurrent Head and Neck Cancer Using Positron Emission Tomography
  Journal of Clinical Oncology, 2000
• Lymph Node Detection of Head and Neck Squamous Cell Carcinomas by Positron Emission Tomography With Fluorodeoxyglucose F 18 in a Routine Clinical Setting
  JAMA Otolaryngology–Head & Neck Surgery, 1999
• Prospective comparison of 18 F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer
  European Journal of Nuclear Medicine and Molecular Imaging, 1998
• The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer1
  Lung Cancer, 1998
• A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma
  Clinical Otolaryngology, 1997
• A comparative diagnostic study of head and neck nodal metastases using positron emission tomography
  The Laryngoscope, 1995